DAVID SIDRANSKY
CIK 1277161 · Chairman of the Board · last filed 2025-11-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.01M
Companies
10
Total Filings
67
Lifetime Open-Market Net
-$311.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CSBR | Director | 770,605 | $6.50 | $5.01M | $0 | 13 | 2025-11-07 |
| ORGS | Director | 180 | $0.49 | $89 | $1.1K | 9 | 2023-12-21 |
| Old Ayala, Inc (AYLA) Delisted | Director | 230 | $0.50 | $116 | $3.7K | 3 | 2022-06-15 |
| Ayala Pharmaceuticals, Inc. (ADXS) Delisted | Director | — | $0.60 | — | $0 | 3 | 2020-05-05 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Director | 110,355 | — | — | $0 | 5 | 2018-06-27 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Director | 80,355 | — | — | -$342.3K | 6 | 2016-08-10 |
| IMMUNE PHARMACEUTICALS INC (IMNP) Delisted | Director | 21,699 | — | — | $26.0K | 2 | 2015-01-12 |
| K-V Pharmaceutical Co (KV.B) Delisted | Director | 1,000 | — | — | $0 | 5 | 2012-05-16 |
| ACEL | Director | — | $13.20 | — | $0 | 4 | 2009-01-05 |
| ZILA INC (ZILA) Delisted | Director | — | — | — | $0 | 1 | 2007-01-10 |
Recent Filings · Page 5 of 7
67 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-12-03 | IMMUNE PHARMACEUTICALS INC (IMNP) Delisted | Buy (P) | +10,400 | $26.0K | EDGAR |
| 2014-10-15 | — | Grant (A) | — | $0 | |
| 2014-07-18 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2014-03-12 | — | Buy (P) | — | $0 | |
| 2013-12-26 | — | Grant (A) | — | $0 | |
| 2013-11-26 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Grant (A) | +10,309 | $50.0K | EDGAR |
| 2013-10-30 | — | Grant (A) | — | $0 | |
| 2013-09-20 | — | Other (J) | −1,000 | $0 | |
| 2013-08-28 | — | Grant (A) | +5,951 | $0 | |
| 2012-07-25 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.